Status History
2026-07-09
OPEN → INELIGIBLE
· VitaDAO exclusively funds longevity and aging research ('a global community on a mission to solve aging'). Eniola's CCT model addresses addiction pharmacology and reward-memory encoding — not aging therapeutics. All 31 funded projects and the entire IPT pipeline are categorised under target discovery, drug discovery, preclinical, and clinical stages for longevity — a fundamental research-focus mismatch with no stated pathway for off-mandate science.